Interesting bio/ intro to company in the above page.
The $10Billion annual sales cardio protection opportunity is what I think it means. As there have been no known major players in this space with likely efficacy and safety of Zantrene this could be an 100% TAM for Race. At 4X valuation for this opportunity should itself value us at $40Bn.
(All guesses. No advice. DYOR)
Interesting bio/ intro to company in the above page. The...
-
- There are more pages in this discussion • 1,185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
-0.010(0.58%) |
Mkt cap ! $301.5M | |||
| Open | High | Low | Value | Volume |
| $1.76 | $1.77 | $1.72 | $112.3K | 64.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2227 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 100 | 1 |
View Market Depth
| Last trade - 13.24pm 23/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |